Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Sara Horst

IBD · Vanderbilt

View

Dr. Laura Sahyoun

IBD · WCM

View

Dr. Uma Mahadevan

IBD · UCSF

View

Dr. Deborah Proctor

IBD · Yale College

View

Dr. Saurabh Sethi

General GI · Oja Health

View

Dr. Nneka Ufere

Liver Transplant · MGH

View

Dr. Wendi LeBrett

General GI · ModernGut

View

Dr. Treta Purohit

General GI · Oshi Health

View

Dr. Rushabh Modi

General GI · Kaiser Permanente

View

Dr. Brennan Spiegel

General GI · Cedars-Sinai

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    GLDr. Garrett Lawlor

    Dr. Garrett Lawlor

    Gastroenterology · Inflammatory Bowel Diseases
    Merck & Co
    garrettl
    New York City, NY, USA

    Research

    Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age

    2026

    Via Inflammatory Bowel Diseases

    Research

    Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis

    2025

    Via Inflammatory Bowel Diseases

    Research

    Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial

    2025

    Via The American Journal of Gastroenterology

    Research

    Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension

    2024

    Via Journal of Crohn's & Colitis

    Research

    The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium

    2022

    Via The American Journal of Gastroenterology

    Research

    Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD

    2021

    Via Digestive Diseases and Sciences

    Research

    Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability

    2021

    Via Clinical Gastroenterology and Hepatology

    Research

    Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease

    2020

    Via Inflammatory Bowel Diseases

    Research

    Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients

    2020

    Via Inflammatory Bowel Diseases

    Research

    Restorative Surgery for Ulcerative Colitis in the Elderly: An Analysis of Ileal Pouch-Anal Anastomosis Procedures from the American College of Surgeons National Surgical Quality Improvement Program

    2020

    Via Techniques in Coloproctology

    Research

    Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD

    2020

    Via Digestive Diseases and Sciences

    Research

    Disability in Inflammatory Bowel Disease Patients Is Associated With Race, Ethnicity and Socio-Economic Factors

    2019

    Via Alimentary Pharmacology & Therapeutics

    Research

    Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile

    2019

    Via Inflammatory Bowel Diseases

    Research

    Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases

    2019

    Via Clinical Gastroenterology and Hepatology

    Research

    Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases

    2019

    Via Clinical Gastroenterology and Hepatology